I. Holmes

发表

Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio

V. Cirillo, G. Hitzenberger, J. Tobert, 1981, Clinical pharmacology and therapeutics.

Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly

A. Richens, J. Mcewen, W. Dieterle, 2004, European Journal of Clinical Pharmacology.

EFFECTIVENESS AND TOLERABILITY OF CV-3988, A SELECTIVE PAF ANTAGONIST, AFTER INTRAVENOUS ADMINISTRATION TO MAN

J. Arnout, J. Vermylen, P. Deschepper, 1988, Thrombosis and Haemostasis.

Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.

G. Hitzenberger, W. Kukovetz, J. Tobert, 1982, Atherosclerosis.

The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.

I. Holmes, G. Hilson, 1972, Journal of medical microbiology.

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

Y. Chao, J. Bolognese, G. Bell, 1982, The Journal of clinical investigation.

Potentiating Effect of Adrenaline on Adenosine Diphosphate - Induced Reduction in Rabbit Circulating Platelet Count: Inhibition by Dihydroergotoxine

I. Holmes, 1979, Thrombosis and Haemostasis.

The Effect of Intravenous Adenosine Diphosphate on the Number of Circulating Platelets in Experimental Animals: Inhibition by Prostaglandin E1, Dipyridamole, SH-869 and VK-774

F. Freuler, I. Holmes, G. Smith, 1977, Thrombosis and Haemostasis.

Use of the Technicon Autocounter for animal platelet counting and for continuous monitoring of circulating platelet number.

F. Freuler, I. Holmes, 1979, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

General aspects of platelet function and methods of measurement.

I. Holmes, 1979, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride

N. Mcintyre, G. Kaiser, I. Holmes, 1990, Biopharmaceutics & drug disposition.

Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.

I. Holmes, 1974, International journal of leprosy and other mycobacterial diseases.

TIONS: MINIMUM INHIBITORY C ONCENTRATIONS AND BACTERICIDAL ACTION EXPERIMENTAL MYCOBACTERIUM LEPRAE INFEC-

I. Holmes, G. Hilson, 1972 .

The activity of various antituberculous drugs in suppressing experimental Mycobacterium leprae infection in mice.

D. Banerjee, I. Holmes, G. Hilson, 1971, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

The Rate of Bactericidal Action of Rifampin on Mycobacterium leprae in the Mouse Footpad

I. Holmes, G. Hilson, 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

R. Verbesselt, G. Kaiser, A. Hecken, 2004, European Journal of Clinical Pharmacology.